351 related articles for article (PubMed ID: 12591093)
1. alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs.
Kalkman HO; Loetscher E
Eur J Pharmacol; 2003 Feb; 462(1-3):33-40. PubMed ID: 12591093
[TBL] [Abstract][Full Text] [Related]
2. Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile.
Schmidt AW; Lebel LA; Howard HR; Zorn SH
Eur J Pharmacol; 2001 Aug; 425(3):197-201. PubMed ID: 11513838
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
Markianos M; Hatzimanolis J; Lykouras L
Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):141-6. PubMed ID: 11697576
[TBL] [Abstract][Full Text] [Related]
4. Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat.
Shirazi-Southall S; Rodriguez DE; Nomikos GG
Neuropsychopharmacology; 2002 May; 26(5):583-94. PubMed ID: 11927183
[TBL] [Abstract][Full Text] [Related]
5. The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063.
Assié MB; Carilla-Durand E; Bardin L; Maraval M; Aliaga M; Malfètes N; Barbara M; Newman-Tancredi A
Eur J Pharmacol; 2008 Sep; 592(1-3):160-6. PubMed ID: 18640111
[TBL] [Abstract][Full Text] [Related]
6. Functional alpha2C-adrenoceptors in human neuroblastoma SH-SY5Y cells.
Parsley S; Gazi L; Bobirnac I; Loetscher E; Schoeffter P
Eur J Pharmacol; 1999 May; 372(1):109-15. PubMed ID: 10374721
[TBL] [Abstract][Full Text] [Related]
7. A model of anticholinergic activity of atypical antipsychotic medications.
Chew ML; Mulsant BH; Pollock BG; Lehman ME; Greenspan A; Kirshner MA; Bies RR; Kapur S; Gharabawi G
Schizophr Res; 2006 Dec; 88(1-3):63-72. PubMed ID: 16928430
[TBL] [Abstract][Full Text] [Related]
8. 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex.
Rollema H; Lu Y; Schmidt AW; Sprouse JS; Zorn SH
Biol Psychiatry; 2000 Aug; 48(3):229-37. PubMed ID: 10924666
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the postjunctional alpha 2C-adrenoceptor mediating vasoconstriction to UK14304 in porcine pulmonary veins.
Görnemann T; von Wenckstern H; Kleuser B; Villalón CM; Centurión D; Jähnichen S; Pertz HH
Br J Pharmacol; 2007 May; 151(2):186-94. PubMed ID: 17375080
[TBL] [Abstract][Full Text] [Related]
10. Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat.
Oerther S; Ahlenius S
J Pharmacol Exp Ther; 2000 Feb; 292(2):731-6. PubMed ID: 10640312
[TBL] [Abstract][Full Text] [Related]
11. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
Ichikawa J; Li Z; Dai J; Meltzer HY
Brain Res; 2002 Nov; 956(2):349-57. PubMed ID: 12445705
[TBL] [Abstract][Full Text] [Related]
12. BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex.
Volonté M; Monferini E; Cerutti M; Fodritto F; Borsini F
J Neurochem; 1997 Jul; 69(1):182-90. PubMed ID: 9202309
[TBL] [Abstract][Full Text] [Related]
13. Postjunctional alpha(2C)-adrenoceptor contractility in human saphenous vein.
Rizzo CA; Ruck LM; Corboz MR; Umland SP; Wan Y; Shah H; Jakway J; Cheng L; McCormick K; Egan RW; Hey JA
Eur J Pharmacol; 2001 Feb; 413(2-3):263-9. PubMed ID: 11226402
[TBL] [Abstract][Full Text] [Related]
14. Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo.
Willins DL; Berry SA; Alsayegh L; Backstrom JR; Sanders-Bush E; Friedman L; Roth BL
Neuroscience; 1999; 91(2):599-606. PubMed ID: 10366017
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade.
Wood MD; Scott C; Clarke K; Cato KJ; Patel N; Heath J; Worby A; Gordon L; Campbell L; Riley G; Davies CH; Gribble A; Jones DN
CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):445-52. PubMed ID: 16918396
[TBL] [Abstract][Full Text] [Related]
16. In vitro functional characteristics of dopamine D2 receptor partial agonists in second and third messenger-based assays of cloned human dopamine D2Long receptor signalling.
Jordan S; Regardie K; Johnson JL; Chen R; Kambayashi J; McQuade R; Kitagawa H; Tadori Y; Kikuchi T
J Psychopharmacol; 2007 Aug; 21(6):620-7. PubMed ID: 17092971
[TBL] [Abstract][Full Text] [Related]
17. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
[TBL] [Abstract][Full Text] [Related]
18. Enhanced efficacy of both typical and atypical antipsychotic drugs by adjunctive alpha2 adrenoceptor blockade: experimental evidence.
Wadenberg ML; Wiker C; Svensson TH
Int J Neuropsychopharmacol; 2007 Apr; 10(2):191-202. PubMed ID: 16707032
[TBL] [Abstract][Full Text] [Related]
19. Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors.
Tadori Y; Forbes RA; McQuade RD; Kikuchi T
Eur J Pharmacol; 2008 Nov; 597(1-3):27-33. PubMed ID: 18831971
[TBL] [Abstract][Full Text] [Related]
20. Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation.
Novi F; Millan MJ; Corsini GU; Maggio R
J Neurochem; 2007 Aug; 102(4):1410-24. PubMed ID: 17532788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
